Chen Jing 4
4 · Biostage, Inc. · Filed Jul 6, 2018
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Conversion
Series D Convertible Preferred Stock
2018-06-29−54→ 0 totalExercise: $2.00From: 2017-12-27→ Common Stock (27,000 underlying) - Conversion
Common Stock
2018-06-29+27,000→ 36,000 total
Footnotes (2)
- [F1]Shares of common stock received upon conversion of Series D Convertible Preferred Stock.
- [F2]The shares of Series D Convertible Preferred Stock have no expiration date.